Hope Biosciences Research Foundation

This phase 2 study tested whether a person's own stem cells (called HB-adMSCs) could help control Parkinson's disease. Twenty-four adults with early to moderate Parkinson's received either stem cells or a placebo over 32 weeks. The main goal was to see if the treatment improved d…

This study tested whether a single type of donated stem cell (HB-adMSCs) could help people with Parkinson's disease. 60 adults aged 45-80 received either the stem cells or a placebo. The goal was to see if the treatment improved movement and daily living skills, and to check for …

This study tested whether a person's own stem cells (called HB-adMSCs) could improve quality of life for people with multiple sclerosis. 24 adults with relapsing-remitting MS received either the stem cells or a placebo through 6 infusions over a year. The main goal was to see if …

This study tested whether infusions of a person's own stem cells could help prevent COVID-19 from causing serious illness. Researchers gave five IV infusions of these cells to 51 adults at high risk, such as those over 65 or with health conditions. The goal was to see if the trea…

This study tested whether five infusions of stem cells (HB-adMSCs) could prevent COVID-19 symptoms and hospitalizations in 53 high-risk workers like doctors and firefighters. Participants had no signs of COVID-19 at the start. The goal was to see if the stem cells could boost the…

This study tested whether stem cell infusions could help people with chronic post-COVID syndrome (Long COVID). 79 adults received four doses of either stem cells or a placebo over 10 weeks. Researchers tracked changes in symptoms like extreme fatigue, brain fog, headaches, and sl…